Sanofi Sponsored ADR Stock News

European drugmakers called for ​beefed-up government spending on medicines, faster trials and IP protections as ‌they sounded warnings on Tuesday that the continent's pharmaceutical industry risks losing out to the United States and China.

Sanofi and  Cheplaphar m to create new strategic partnership i n mature medicines

MORRISTOWN, N.J. and SCOTTSDALE, Ariz., Sept. 10, 2026 /PRNewswire/ -- Sanofi and USA Pickleball are teaming up to launch "Serve Up Protection," a campaign to educate older adults about COVID-19 and NUVAXOVID (COVID-19 Vaccine, Adjuvanted), the only protein-based, non-mRNA COVID-19 vaccine approved by the US Food and Drug Administration (FDA). "Serve Up Protection" aims to reach people during t...

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi and ​Pfizer-BioNTech's updated COVID vaccines, the companies ‌said on Thursday, after an advisory panel recommended that the shots should target ​the dominant XFG variant.

Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Paris, August 4, 2026. Sanofi today announced that the European Commission (EC) has approved an extension of the indication for MenQuadfi (Meningococcal Group A, C, W and Y conjugate vaccine) to include infants from six weeks of age to help protect against invasive meningococcal di...

The company now expects 2026 sales to grow by around 10% excluding currency changes, with business earnings per share rising slightly faster than sales.

Sanofi on Thursday raised its full-year sales forecast on the ​back of strong demand for blockbuster ‌asthma drug Dupixent, with investors focused on new CEO Belen Garijo's first address for her plans ​to revive the French company's drug development ​engine.